Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Accumulated Expenses (2022 - 2023)

Silo Pharma's Accumulated Expenses history spans 2 years, with the latest figure at $5891.0 for Q4 2023.

  • For Q4 2023, Accumulated Expenses fell 95.9% year-over-year to $5891.0; the TTM value through Dec 2023 reached $5891.0, down 95.9%, while the annual FY2023 figure was $5891.0, 95.9% down from the prior year.
  • Accumulated Expenses for Q4 2023 was $5891.0 at Silo Pharma, down from $20134.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $143607.0 in Q4 2022 and bottomed at $5891.0 in Q4 2023.